Compliance Certificate u/r 74(5) of SEBI(DP) Reg. 2018 for March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech has submitted a routine compliance certificate under SEBI's Depository Regulations for the January–March 2025 quarter. This certificate is filed by the company's Registrar and Share Transfer Agent and confirms that physical share certificates received for dematerialisation during the quarter were properly cancelled and destroyed after the shares were credited to investors' demat accounts. No financial numbers, business update, or strategic information is included in this filing. The submission is mandatory every quarter for all listed companies that have a registered RTA.
Purely procedural regulatory compliance — no effect on the company's financials, operations, or shareholder value. Investors can safely ignore this for any investment decision.